HVJ (Sendai virus) liposome-mediated gene transfer: Current status and future perspectives

International Journal of Oncology

Volumn 12, Issue 6, 1998, Pages 1277-1285

  Yonemitsu, Yoshikazu ^a,b   Alton, Eric W F W ^a   Komori, Kimihiro ^b   Yoshizumi, Tomoharu ^b   Sugimachi, Keizo ^b   Kaneda, Yasufumi ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Gene therapy; HVJ liposomes

Indexed keywords

LIPOSOME;

ARTICLE; CARDIOVASCULAR SYSTEM; CYSTIC FIBROSIS; DNA TRANSFER; EXPRESSION VECTOR; GENE CASSETTE; GENE THERAPY; GENE TRANSFER; HEPATOBILIARY SYSTEM; PRIORITY JOURNAL; SENDAI VIRUS; VIRUS ENVELOPE;

EID: 0031865751     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Greber UF, Willetts M, Webster P and Helenius A: Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477-486, 1993.
2. Feigner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM and Danielsen M: Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413-7417, 1987.
3. Okada Y: Factors in fusion of cells by HVJ. Curr Top Microbiol Immunol 48: 102-128, 1969.
4. Kaneda Y, Uchida T, Kim J, Ishiura M and Okada Y: The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gancliosides. Exp Cell Res 173: 56-69, 1987.
5. Yonemitsu Y, Kaneda Y, Muraishi A, Yoshizumi T, Sugimachi K and Sueishi K: HVJ (Sendai virus)-cationic liposomes: a novel and potentially effective liposome-mediated technique for gene transfer to the airway epithelium. Gene Ther 4: 631-638, 1997.
6. Kaneda Y, Iwai K and Uchida T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375-378, 1989.
7. Yonemitsu Y, Kaneda Y, Morishita R, Nakagawa K, Nakashima Y and Sueishi K: Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (HVJ)-liposomes: an effective tool for the in vivo study of arterial diseases. Lab Invest 75: 313-323, 1996.
8. Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K and Kaneda Y: Development and characterization of cationic liposomes conjugated HVJ (Sendai virus): reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Hum Gene Ther 8: 2133-2141, 1997.
9. Yoshizumi T, Yonemitsu Y, Yanaga K, Kaneda Y, Sugimachi K and Sueishi K: A novel and highly efficient delivery system for oligo-deoxynucleotides transfer to the Kupffer cells in the hepatic graft. Transplantation (In press).
10. Morishita R, Gibbons GH, Kaneda Y, Ogihara T and Dzau VJ: Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for rcstenosis by HVJ-liposome delivery. Gene 149: 13-19, 1994.
11. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T and Dzau VJ: Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 90: 8474-8478, 1993.
12. Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T and Dzau VJ: Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 93: 1458-1464, 1994.
13. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T and Dzau VJ: A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 92: 5855-5859, 1995.
14. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J and Ogihara T: In vivo transfection of cis element 'decoy' against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3: 894-899, 1997.
15. Von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda Y, Cooke JP and Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137-1141, 1995.
16. Matsumoto T, Komori K, Yonemitsu Y, Kaneda Y, Morishita R, Sueishi K and Sugimachi K: HVJ liposome-mediated gene transfer of endothelial cell nitric oxide synthese inhibits intimai hyperplasia of canine vein grafts under poor run-off conditions. J Vasc Surg 27: 135-144, 1998.
17. Yonemitsu Y, Kaneda Y, Hata Y, Nakashima Y and Sueishi K: Wild-type p53 gene transfer: a novel therapeutic strategy for neointimal hyperplasia after arterial injury. Ann NY Acad Sci 811: 395-400, 1997.
18. Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K and Sueishi K: Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82: 147-156, 1998.
19. Feldman LJ, Steg PG, Zheng LP, Chen D, Kearney M, McGarr SE, Barry JJ, Dedieu JF, Perricaudet M and Isner JM: Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest 95: 2262-2671, 1995.
20. Kaneda Y, Iwai K and Uchida T: Introduction and expression of the human insulin gene in adult rat liver. J Biol Chem 264: 12126-12129, 1989.
21. Kato K, Nakanishi M, Kaneda Y, Uchida T and Okada Y: Expression of hepatitis B virus surface antigen in adult rat liver: Co-introduction of DNA and nuclear protein by a simplified liposome method. J Biol Chem 266: 3361-3364, 1991.
22. Rosenfeld MA, Yoshimura K, Trapell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L and Crystal RG: In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143-155, 1992.
23. Mastrangeli A, Danel C, Rosenfeld MA, Stratford-Perricaudet L, Pericaudet M, Pavirani A, Lecocq JP and Crystal RG: Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. J Clin Invest 91: 225-234, 1993.
24. Grubb BR, Pickles RJ, Ye H, Yankaskas JR, Vick RN, Engelhardt JF, Wilson JM, Johnson LG and Boucher RC: Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 371: 802-806, 1994.
25. Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR, Grossman M, Wilson JM, Johnson LG and Boucher RC: A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Eng J Med 333: 823-831, 1995.
26. 5 integrin is neccessary for efficient adenovirus-mediated gene transfer in the human airway. J Virol 69: 5951-5958, 1995.
27. Crystal RG, McElvaney NG, Rosenfeld MA, Chu CS, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT and Danel C: Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 8:42-51, 1994.
28. Gorziglia MI, Kadan MJ, Yei S, Lim J, Lee GM, Luthra R and Trapnell BC: Elimination of both E1 and E2a from adenovirus vectors further improves prospects for in vivo human gene therapy. J Virol 70: 4173-4178, 1996.
29. Yeh P, Dedieu JF, Orsini C, Vigne E, Denefle P and Perricaudet M: Efficient dual trans-complementation of adenovirus E1 and E4 region from a 293-derived cell line expressing a minimal E4 function unit. J Virol 70: 559-565, 1996.
30. Lei D, Lehmann M, Shellito JE, Nelson S, Siegling A, Volk HD and Kolls JK: Nondepleting anti-CD4 antibody treatment prolongs lung-directed El-deleted adenovirus-mediated gene expression in rats. Hum Gene Ther 7: 2273-2279, 1996.
31. Yang Y, Trinchieri G and Wilson JM: Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1: 890-893, 1995.
32. Klonjkowski B, Gilardi-Hebenstreit P, Hadchouel J, Randrianarison V, Boutin S, Yeh P, Perricaudet M and Kremer EJ: A recombinant El-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum Gene Ther 8: 2103-2115, 1997.
33. Alton EWFW, Middleton PG, Caplen NJ, Smith SN, Steel DM, Munkonge FM, Jeffery PK, Geddes DM, Hart SL, Williamson R, Fasold KI, Miller AD, Dickinson P, Stevenson BJ, MacLachlan G, Dorin JR and Porteus DJ: Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 5: 135-142, 1993.
34. Caplen NJ, Alton EWFW, Middleton PG, Dorin JR, Stevenson BJ, Gao X, Durham SR, Jeffery PK, Hodson ME, Coutelle C, Huang L, Porteus DJ, Williamson R and Geddes DM: Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1: 39-46, 1995.
35. Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nicols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX, Wan NC and Scheule RK: Detailed analysis of structures and formulations of cationic lipids for gene transfer to the lung. Hum Gene Ther 7: 1701-1717, 1996.
36. Zabner J, Cheng SH, Meeker D, Launspach J, Balfour R, Perricone MA, Morris JE, Marshall J, Fasbender A, Smith AE and Welsh MJ: Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J Clin Invest 100: 1529-1537, 1997.
37. Duncan JE, Whitsett JA and Horowitz AD: Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. Hum Gene Ther 8: 431-438, 1997.
38. Tsan MF, Tsan GL and White JE: Surfactant inhibits cationic liposome-mediated gene transfer. Hum Gene Ther 8: 817-825, 1997.
39. Stern M, Caplen NJ, Browning JE, Griesenbach U, Sorgi F, Huang L, Gruenert DC, Marriot C, Crystal RG, Geddes DM and Alton EWFW: The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther 5: 91-98, 1998.
40. Matsui H, Johnson LG, Randell SH and Boucher RC: Loss of binding and entry of liposome-DNA complexes decreases transfection efficiency in differentiated airway epithelial cells. J Biol Chem 272: 1117-1126, 1997.
41. Yoshida M, Sakuma J, Hayashi S, Abe K, Saito I, Harada S, Sakatani M, Yamamoto S, Matsumoto N and Kaneda Y: A histologically distinctive interstitial pneumonia induced by overexpression of interleukin 6, transforming growth factor beta 1, or pletelet-derived growth factor B gene. Proc Natl Acad Sci USA 92: 9570-9674, 1995.
42. Takeda S, Sawa Y, Minami M, Kaneda Y, Fujii Y, Shirakura R, Yanagisawa M and Matsuda H: Experimental bronciolitis obliterans induced by in vivo HVJ-liposome-mediated endothelin-1 gene transfer. Ann Thorac Surg 63: 1562-1567, 1997.
43. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL and Anderson NVF: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4: 39-69, 1993.
44. Sawamura D, Meng X, Ina S, Ishikawa H, Tamai K, Nomura K, Hanada K, Hashimoto I and Kaneda Y: In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method. J Invest Dermatol 108: 195-199, 1997.
45. Mabuchi E, Shimizu K, Miyao Y, Kaneda Y, Kishima H, Tamura M, Ikenaka K and Hayakawa T: Gene delivery by HVJ-liposome in the experimental gene therapy of murine glioma. Gene Ther 4: 768-772, 1997.
46. Vogelstein BX and Kinzler KW: p53 function and dysfunction. Cell 70: 523-526, 1992.
47. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
48. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
49. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
50. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KM, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T and Cai D: Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985-991, 1996.
51. Brachmann RK, Vidai M and Boeke JD: Dominant-negative p53 mutations selected in yeast hit cancer host spots. Proc Natl Acad Sci USA 93: 4091-4095, 1996.
52. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW and Vogelstein B: Definition of a consensus binding site for p53. Nat Genet 1: 45-49, 1992.
53. Namoto M, Yonemitsu Y, Nakagawa K, Hashimoto S, Kaneda Y, Nawata H and Sueish K: Heterogenous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection. Int J Oncol 12: 777-784, 1998.
54. Nabel GJ, Nabel Eg, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D and Chang AE: Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity and lack of toxicity in humans. Proc Natl Acad Sci USA 90: 11307-11311, 1993.
55. Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD and Hoon DS: Induction of antibody response to human tumor antigens by gene therapy using fusigenic viral liposome vaccine. Gene Ther 4: 969-976, 1997.
56. Hangai M, Kaneda Y, Tanihara H and Honda Y: In vivo gene transfer into the retina mediated by a novel liposome system. Invest Opthalmol Vis Sci 37: 2678-2685, 1996.
57. Akagi Y, Isaka Y, Arai M, Kaneko T, Takenaka M, Moriyama T, Kaneda Y, Ando A, Orita Y, Kamada T, Ueda N and Imai E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50: 148-155, 1996.
58. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA and Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2: 418-423, 1996.